• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 HIV 血清不一致的伴侣关系中,东非女性口服暴露前预防(PrEP)的依从模式和 HIV 风险。

Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships.

机构信息

Department of Epidemiology, University of Washington, Seattle, USA.

Department of Global Health, University of Washington, 325 Ninth Avenue, Box 359927, Seattle, WA, 98104, USA.

出版信息

AIDS Behav. 2018 Nov;22(11):3718-3725. doi: 10.1007/s10461-018-2221-3.

DOI:10.1007/s10461-018-2221-3
PMID:30006791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6330257/
Abstract

Understanding how women use PrEP is important for developing successful implementation programs. We hypothesized there are distinct patterns of adherence, related to HIV risk and other factors. We identified patterns of PrEP adherence and HIV risk behavior over the first 6 months of PrEP use, using data from 233 HIV-uninfected women in high-risk serodiscordant couples in a demonstration project in Kenya & Uganda. We modeled PrEP adherence, assessed by daily electronic monitoring, and HIV risk behavior using group-based trajectory models. We tested baseline covariates and risk behavior group as predictors of adherence patterns. There were four distinct adherence patterns: high steady adherence (55% of population), moderate steady (29%), late declining (8%), and early declining (9%). No baseline characteristics significantly differed between adherence patterns. Adherence patterns differed in average weekly doses (6.7 vs 5.4 vs 4.1 vs 1.5, respectively). Two risk behavior groups were identified: steady HIV risk (78% of population) and declining (22%). Compared to women with declining HIV risk behavior, women with steady risk behavior were more likely to have high steady adherence (61% vs 35%) and less likely to have early (6% vs 17%) or late (4% vs 19%) declining adherence. Women's use of PrEP was associated with concurrent HIV risk behavior; higher risk was associated with higher, sustained adherence.

摘要

了解女性如何使用 PrEP 对于制定成功的实施计划非常重要。我们假设存在与 HIV 风险和其他因素相关的不同的 PrEP 依从模式。我们使用肯尼亚和乌干达一个示范项目中 233 名感染 HIV 但未感染的高危血清不一致夫妇的数据,确定了在 PrEP 使用的前 6 个月内 PrEP 依从性和 HIV 风险行为的模式。我们使用基于群组的轨迹模型对 PrEP 依从性进行建模,该模型通过每日电子监测进行评估,并对 HIV 风险行为进行建模。我们检验了基线协变量和风险行为群组对依从模式的预测作用。存在四种不同的依从模式:高稳定依从(占人口的 55%)、中等稳定(29%)、晚期下降(8%)和早期下降(9%)。基线特征在依从模式之间没有显著差异。平均每周剂量在不同的依从模式中有所不同(分别为 6.7、5.4、4.1 和 1.5)。确定了两个风险行为群组:稳定的 HIV 风险(占人口的 78%)和下降(22%)。与 HIV 风险行为下降的女性相比,风险行为稳定的女性更有可能具有高稳定的依从性(61% 比 35%),而早期(6% 比 17%)或晚期(4% 比 19%)下降的依从性较低。女性使用 PrEP 与同时发生的 HIV 风险行为相关;更高的风险与更高、持续的依从性相关。

相似文献

1
Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships.在 HIV 血清不一致的伴侣关系中,东非女性口服暴露前预防(PrEP)的依从模式和 HIV 风险。
AIDS Behav. 2018 Nov;22(11):3718-3725. doi: 10.1007/s10461-018-2221-3.
2
Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.肯尼亚和乌干达艾滋病毒血清学不一致伴侣暴露前预防示范项目中依从性与艾滋病毒感染风险的比对:预防有效依从性的前瞻性分析
J Int AIDS Soc. 2017 Jul 25;20(1):21842. doi: 10.7448/IAS.20.1.21842.
3
Alignment of PrEP use and effective contraceptive use among East African women in HIV serodiscordant partnerships.在 HIV 血清不一致的伴侣关系中,东非妇女中预防母婴传播用药和有效避孕措施的使用一致性。
Int J STD AIDS. 2020 Nov;31(13):1263-1271. doi: 10.1177/0956462420951501. Epub 2020 Sep 30.
4
Brief Report: PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships.简短报告:血清学不一致关系中的东非女性在HIV风险期使用暴露前预防药物的情况
J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):41-45. doi: 10.1097/QAI.0000000000001561.
5
Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.向HIV-1血清学不一致的夫妇综合提供抗逆转录病毒治疗和暴露前预防:在肯尼亚和乌干达进行的一项前瞻性实施研究。
PLoS Med. 2016 Aug 23;13(8):e1002099. doi: 10.1371/journal.pmed.1002099. eCollection 2016 Aug.
6
"Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.“由于我们两人都在使用抗逆转录病毒药物,所以一直相互支持”:肯尼亚基苏木异性恋HIV血清学不一致伴侣中暴露前预防用药的促进因素和障碍
J Int AIDS Soc. 2016 Dec 12;19(1):21134. doi: 10.7448/IAS.19.1.21134. eCollection 2016.
7
High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis.在接受抗逆转录病毒药物预先暴露预防的临床试验中,HIV-1 未感染女性在围孕期的药物依从性较高。
J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):91-7. doi: 10.1097/QAI.0000000000000246.
8
Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the "PrEP as a bridge to ART" strategy.东非艾滋病毒血清学不一致夫妇对艾滋病治疗(ART)建议及针对性暴露前预防(PrEP)使用的依从性:“PrEP作为通向ART的桥梁”策略
BMC Public Health. 2020 Oct 28;20(1):1621. doi: 10.1186/s12889-020-09712-3.
9
Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.抗逆转录病毒预防 HIV 感染的依从性:东非血清学不一致夫妇临床试验中的子研究队列。
PLoS Med. 2013;10(9):e1001511. doi: 10.1371/journal.pmed.1001511. Epub 2013 Sep 10.
10
No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda.肯尼亚和乌干达异性 HIV 血清不一致夫妇中,在开始接受 PrEP 后没有发现性风险补偿的证据。
AIDS Behav. 2020 May;24(5):1365-1375. doi: 10.1007/s10461-019-02720-4.

引用本文的文献

1
The Association Between Use of Adherence Support Interventions and Adherence to HIV Preexposure Prophylaxis Among Young South African and Zimbabwean Women in HPTN 082.在HPTN 082研究中,南非和津巴布韦年轻女性使用依从性支持干预措施与坚持HIV暴露前预防之间的关联
AIDS Behav. 2025 Apr 10. doi: 10.1007/s10461-025-04709-8.
2
Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women.南非艾滋病毒暴露女性在受孕期间每日口服替诺福韦酯/恩曲他滨暴露前预防用药的依从性。
Front Reprod Health. 2023 Oct 4;5:1263422. doi: 10.3389/frph.2023.1263422. eCollection 2023.
3
Patterns of PrEP continuation and coverage in the first year of use: a latent class analysis of a programmatic PrEP trial in Kenya.

本文引用的文献

1
Recent HIV Risk Behavior and Partnership Type Predict HIV Pre-Exposure Prophylaxis Adherence in Men Who Have Sex with Men.最近的艾滋病毒风险行为和伙伴关系类型预测男男性行为者中 HIV 暴露前预防的依从性。
AIDS Patient Care STDS. 2019 May;33(5):220-226. doi: 10.1089/apc.2018.0289.
2
Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.在非洲女性中进行每日和非每日暴露前预防(HPTN 067/ADAPT 开普敦试验):一项随机、开放标签、2 期试验。
Lancet HIV. 2018 Feb;5(2):e68-e78. doi: 10.1016/S2352-3018(17)30156-X. Epub 2017 Oct 3.
3
Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
在使用的第一年中,PrEP 持续使用和覆盖模式:肯尼亚方案性 PrEP 试验的潜在类别分析。
J Int AIDS Soc. 2023 Jul;26(7):e26137. doi: 10.1002/jia2.26137.
4
Changes in HIV Prevention and Sexual Experiences During the COVID-19 Pandemic: A Mixed-Methods Study.《COVID-19 大流行期间艾滋病毒预防和性经历的变化:混合方法研究》
J Acquir Immune Defic Syndr. 2023 Oct 1;94(2):143-150. doi: 10.1097/QAI.0000000000003229.
5
High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study.在乌干达农村,有个人或伴侣计划怀孕的 HIV 暴露妇女中,高比例的 PrEP 使用率和客观的纵向依从性:一项队列研究。
PLoS Med. 2023 Feb 16;20(2):e1004088. doi: 10.1371/journal.pmed.1004088. eCollection 2023 Feb.
6
Casting a Wide Net: HIV Drug Resistance Monitoring in Pre-Exposure Prophylaxis Seroconverters in the Global Evaluation of Microbicide Sensitivity Project.广泛撒网:在全球杀微生物剂敏感性项目中,对暴露前预防血清转换者中的 HIV 耐药性监测。
Glob Health Sci Pract. 2022 Apr 29;10(2). doi: 10.9745/GHSP-D-21-00122. Print 2022 Apr 28.
7
Kidney function in tenofovir disoproxil fumarate-based oral pre-exposure prophylaxis users: a systematic review and meta-analysis of published literature and a multi-country meta-analysis of individual participant data.基于富马酸替诺福韦二吡呋酯的口服暴露前预防用药者的肾功能:文献系统评价和荟萃分析及多国个体参与者数据荟萃分析。
Lancet HIV. 2022 Apr;9(4):e242-e253. doi: 10.1016/S2352-3018(22)00004-2. Epub 2022 Mar 7.
8
HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity.HIV 暴露前预防与性传播感染:交叉与机遇。
Nat Rev Urol. 2022 Jan;19(1):7-15. doi: 10.1038/s41585-021-00527-4. Epub 2021 Oct 25.
9
Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence.长期 HIV 暴露前预防轨迹在少数族裔患者中的表现:短暂、下降和持续的依从性。
J Acquir Immune Defic Syndr. 2022 Feb 1;89(2):166-171. doi: 10.1097/QAI.0000000000002833.
10
Derivation of an HIV Risk Score for African Women Who Engage in Sex Work.非洲从事性工作的女性 HIV 风险评分的推导。
AIDS Behav. 2021 Oct;25(10):3292-3302. doi: 10.1007/s10461-021-03235-7. Epub 2021 Apr 16.
肯尼亚和乌干达艾滋病毒血清学不一致伴侣暴露前预防示范项目中依从性与艾滋病毒感染风险的比对:预防有效依从性的前瞻性分析
J Int AIDS Soc. 2017 Jul 25;20(1):21842. doi: 10.7448/IAS.20.1.21842.
4
"Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.“由于我们两人都在使用抗逆转录病毒药物,所以一直相互支持”:肯尼亚基苏木异性恋HIV血清学不一致伴侣中暴露前预防用药的促进因素和障碍
J Int AIDS Soc. 2016 Dec 12;19(1):21134. doi: 10.7448/IAS.19.1.21134. eCollection 2016.
5
Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention.使用风险评分工具识别感染HIV-1血清学不一致的高危夫妇,以便进行基于抗逆转录病毒药物的HIV-1预防干预。
BMC Infect Dis. 2016 Oct 17;16(1):571. doi: 10.1186/s12879-016-1899-y.
6
Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.向HIV-1血清学不一致的夫妇综合提供抗逆转录病毒治疗和暴露前预防:在肯尼亚和乌干达进行的一项前瞻性实施研究。
PLoS Med. 2016 Aug 23;13(8):e1002099. doi: 10.1371/journal.pmed.1002099. eCollection 2016 Aug.
7
Perceived Risk Among Human Immunodeficiency Virus Serodiscordant Couples in East Africa Taking Oral Pre-Exposure Prophylaxis.东非接受口服暴露前预防的艾滋病毒血清学不一致伴侣中的感知风险
Sex Transm Dis. 2016 Aug;43(8):471-5. doi: 10.1097/OLQ.0000000000000472.
8
Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.在开普敦女性中开展的HPTN 067/ADAPT研究提供的开放标签暴露前预防经验:相互性框架内的促进因素和障碍
AIDS Behav. 2017 May;21(5):1361-1375. doi: 10.1007/s10461-016-1458-y.
9
Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa.东非血清学不一致夫妇中预防HIV感染暴露前预防的主观和客观依从性测量方法比较
AIDS. 2016 Apr 24;30(7):1121-9. doi: 10.1097/QAD.0000000000001024.
10
Participants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial.女性暴露前预防临床试验中参与者对不依从的解释。
J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):452-61. doi: 10.1097/QAI.0000000000000880.